Today: 27 June 2026
Hermes stock price holds near €2,055 as results near — what to watch before Monday
8 February 2026
1 min read

Hermes stock price holds near €2,055 as results near — what to watch before Monday

Paris, Feb 8, 2026, 21:15 CET — The market has shut its doors for the day.

Hermes International (HRMS.PA) finished at 2,055 euros, a 0.3% gain, as trading picks up again Monday following a subdued Friday close. Shares fluctuated from 2,001 to 2,063 euros in the previous session, according to LSEG data, and have swung between 1,992.5 and 2,957 euros over the last year.

Hermès is set to report its 2025 annual results on February 12, with a company webcast kicking off at 9 a.m. in Paris. For Paris-listed consumer stocks, that announcement stands out as one of the next key updates after a volatile start to February.

Timing is key here, as investors process sharp shifts in global equities, cash leaving packed trades for bargain plays. “The selloff in the names that carried markets higher may have paused,” said Tim Murray, capital markets strategy at T. Rowe Price. But there’s still a scramble—he notes investors are “chasing to buy cheaper companies.” Reuters

European markets found some footing Friday, with the STOXX 600 climbing 0.9%, according to Reuters, despite earnings surprises rattling individual stocks. The index closed the week roughly 1% higher.

Hermes faces a straightforward test right now: Was growth sustained through the end of the year without resorting to bigger discounts, and is the company able to maintain its margins as expenses and currency swings come into play?

Investors are eyeing specifics on regional demand—Asia, in particular—as well as the split between price-driven gains and volume growth. Hermes doesn’t usually give explicit guidance, though even small changes in tone can move the stock fast.

Then there’s the peer comparison. Investors in luxury tend to stack Hermes next to French competitors LVMH and Kering, as well as Swiss group Richemont. They’re scanning for any sign—however faint—that the sector’s slowdown might be lifting, or simply shifting elsewhere.

The real worry runs in the opposite direction. Hermes continues to wear the “safe” luxury label, but that comes with little room for error; if sales disappoint, management sounds wary about demand, or margins slip, the stock would probably take the hit before the tough questions even start.

The broader market action this week isn’t making things straightforward. Reuters’ “Morning Bid” podcast pointed to a packed global agenda: U.S. jobs and inflation releases, ongoing turbulence in AI-driven tech stocks—moves that often ripple through rates and currencies, sometimes hitting European exporters. Reuters

Hermes traders are left waiting for Thursday’s annual results and the follow-up briefing—those are the real triggers ahead. With the stock opening again on Monday, there’s not much on the table to work with until those numbers drop.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • 4DMedical (ASX:4DX) Gains Investor Attention Ahead of Life Sciences Forum
    June 27, 2026, 4:52 PM EDT. 4DMedical (ASX:4DX) has seen a resurgence in investor interest ahead of its June 24 presentation at the Life Sciences Virtual Investor Forum. CEO Andreas Fouras will discuss the company's respiratory imaging technology and strategic positioning in the US and Australia. Despite recent short-term volatility with shares down 9% on the day and 8% over the week, the stock has surged 25% over the past month. The company's innovative non-invasive, contrast-free lung scanning CT:VQ technology underpins optimistic long-term momentum, though shares trade about 19% below the A$4.97 analyst price target. Market sentiment remains divided, with a significant undervaluation narrative suggesting a fair value of A$11.11, contingent on rapid adoption and high margins. Investors face balancing growth expectations against risks including slower uptake and pricing pressures.

Latest articles

IHG buyback near record highs puts capital-return math in focus

IHG buyback near record highs puts capital-return math in focus

27 June 2026
IHG bought back 200,000 shares for $34 million at near-record prices through June 25, shrinking its share count as its London stock closed Friday at $171.55, just 2.4% below its all-time high; this aggressive buyback, part of a new $950 million program, means future per-share growth will rely more on room and fee expansion, with investors eyeing upcoming half-year results on August 11.
NextEra Energy (NYSE:NEE) lags utilities as tax-credit deadline nears

NextEra Energy (NYSE:NEE) lags utilities as tax-credit deadline nears

27 June 2026
NextEra Energy (NEE) closed up 0.98% at $88.56 on Friday with volume 144% of its 65-day average, but underperformed the Utilities Select Sector SPDR Fund (XLU) despite being its largest holding, as investors weighed deal and project risks ahead of a July 4 clean-energy tax-credit deadline that could impact project economics.
Texas Instruments stock price slips despite chip rally; what TXN holders watch into Monday
Previous Story

Texas Instruments stock price slips despite chip rally; what TXN holders watch into Monday

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data
Next Story

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data

Go toTop